Yoon; Ho Sup

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yoon; Ho Sup.The latest application filed is for "prostaglandin analogs and uses thereof".

Company Profile

5.6.6

Yoon; Ho Sup - Singapore SG
Yoon; Ho Sup - Nanyang SG
Yoon; Ho Sup - Vernon Hills IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Co-crystals of Nurr1-LBD in complex with a cyclopentenone prostaglandin and modulators of Nurr1 Grant 11,406,610 - Yoon , et al. August 9, 2	2022-08-09
Anti-inflammatory composition Grant 11,298,353 - Youn , et al. April 12, 2	2022-04-12
Prostaglandin Analogs And Uses Thereof App 20210139435 - Yoon; Cheolhwan ; et al.	2021-05-13
Anti-inflammatory Composition App 20210060007 - YOUN; Byung Soo ; et al.	2021-03-04
Use of chromone derivative as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity Grant 10,744,113 - Youn , et al. A	2020-08-18
Use of eupatilin as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity Grant 10,744,114 - Youn , et al. A	2020-08-18
Co-crystals Of Nurr1-lbd In Complex With A Cyclopentenone Prostaglandin And Modulators Of Nurr1 App 20200038352 - YOON; Ho Sup ; et al.	2020-02-06
Substituted Chromenes For Treatment Of Fibrosis Or Non-alcoholic Steatohepatitis App 20190263789 - YOUN; Byung Soo ; et al.	2019-08-29
Substituted chromenes for treatment of fibrosis or non-alcoholic steatohepatitis Grant 10,370,364 - Youn , et al.	2019-08-06
New Use Of Chromone Derivative As Pharmaceutical Composition For Prevention And Treatment Of Fibrosis Using Emt Inhibitory Activ App 20190231739 - YOUN; Byung Soo ; et al.	2019-08-01
Use Of Chromone Derivative As Pharmaceutical Composition For Prevention And Treatment Of Fibrosis Using Emt Inhibitory Activity App 20170239211 - YOUN; Byung Soo ; et al.	2017-08-24
Mutant Bcl-2 proteins and uses thereof Grant 7,226,992 - Fesik , et al. June 5, 2	2007-06-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.